PerkinElmer Inc is primarily active in the scientific research and diagnostics industries.

PerkinElmer Inc faces competition from various companies in the market. Some of the main competitors of PerkinElmer Inc include Thermo Fisher Scientific Inc, Agilent Technologies Inc, Waters Corporation, and Bio-Rad Laboratories Inc. These companies also operate in the life science and analytical instrument industries, providing similar products and services. However, PerkinElmer Inc maintains a strong position in the market, leveraging its technological advancements, product innovation, and customer-centric approach to stay competitive in the industry.

PerkinElmer Inc is a highly recognized company in the field of diagnostics, life science research, and applied services. With a rich history dating back to 1937, PerkinElmer Inc has established itself as a global leader in providing innovative solutions to the scientific community. The company's commitment to improving human and environmental health is evident through its extensive range of products, technologies, and services. PerkinElmer Inc actively collaborates with research institutions, pharmaceutical companies, and government agencies to deliver cutting-edge solutions for various scientific challenges. Continuously evolving and expanding, PerkinElmer Inc remains dedicated to driving advancements and enabling breakthrough discoveries in the realms of health, safety, and environmental sustainability.

PerkinElmer Inc has accomplished several significant milestones throughout its history. With over 80 years of experience, the company has become a global leader in providing scientific solutions and technologies. Some notable achievements include the development of innovative diagnostic tools that have revolutionized healthcare, the continuous expansion of its product offering to various industries, and strategic partnerships with leading organizations. PerkinElmer Inc has also received recognition for its commitment to sustainability and social responsibility. These achievements have solidified PerkinElmer Inc's reputation as a trusted provider of high-quality scientific products and services, driving its continuous growth in the market.

PerkinElmer Inc is primarily present in various countries and regions worldwide. As a global leader in life sciences and diagnostics, PerkinElmer has a strong presence in North America, Europe, Asia Pacific, and Latin America. The company operates in over 150 countries, serving customers in academic institutions, government organizations, pharmaceutical companies, and research laboratories. With its expansive reach, PerkinElmer aims to provide innovative solutions and technologies to support advancements in human and environmental health across international borders.

PerkinElmer Inc is a leading global company that specializes in providing innovative solutions for diagnostics, life sciences, and applied services. The company aims to improve the health and well-being of people worldwide through its advanced technologies and scientific expertise. PerkinElmer Inc is committed to delivering reliable and accurate results to its customers, ensuring high-quality products and services. The company's corporate philosophy revolves around promoting sustainability, diversity, and social responsibility. With a strong focus on research and development, PerkinElmer Inc continually strives to drive technological advancements in various industries, making it a trusted leader in its field.

Analysts currently set an average price target of 120,44 USD for the Revvity stock (median: 118,83 USD), implying +7,0 % versus the latest price. The consensus is based on 26 analyst ratings.

Revvity Analyytikkojen kursstavoitteet 2026

26 analysts currently rate the Revvity stock: 15 recommend buying, 10 holding and 1 selling. For 2026, analysts expect Revvity to generate revenue of 2,83 Mrd. USD and earnings per share of 5,25 USD.

Revvity Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Revvity share trades at 97,75 EUR (112,52 USD).

The Revvity share (RVTY) is listed on 7 stock exchanges, including: NYSE (PKI), Frankfurt (PKN.F), München (PKN.MU), Düsseldorf (PKN.DU), London (0KHE.L), London (0KHE.L), SIX (Zürich) (PKN.SW).

PerkinElmer Inc. is an internationally operating company specializing in the provision of products and services in the fields of life sciences, diagnostics, environmental analysis, and other related markets. The company is headquartered in Waltham, Massachusetts and employs over 13,000 employees worldwide. PerkinElmer offers a wide range of products and services tailored to the needs of its customers. In the field of life sciences, PerkinElmer focuses on researching drug candidates to develop new therapeutics and diagnostic methods. The company offers a variety of instruments, software, and reagents that support laboratory analysis. Diagnostics is another important business area for PerkinElmer. In this area, the company provides products that are tailored to the needs of end consumers. This includes devices for prenatal diagnostics, in-house laboratory diagnostics, and tests in the field of genetic diseases. Another core area of PerkinElmer is environmental analysis. PerkinElmer has a long history in the development and manufacture of instruments and consumables used to identify environmental pollutants and other similar influences. The product range includes chromatography equipment, mass spectrometers, reactive chemicals, and software solutions. PerkinElmer is also active in the field of food analysis. This includes products for the identification of food allergens, analysis of nutritional aspects, and residues of pesticides and other pollutants. Another division involves supporting customers with technical support, such as installation and commissioning of instruments, application questions, and the development of test methods. PerkinElmer also offers research and development services tailored to the needs of its customers. These services include the validation of test methods, testing for the detection of pollutants, and the introduction of automation solutions in the production process. PerkinElmer has expanded its business model to fully meet the needs of its customers. The company builds on its strong expertise and history to offer high-quality products and services. Due to its wide range of products and services, PerkinElmer has expanded into several international markets. The company strives to initiate acquisitions and mergers to continuously expand its business areas. The geographical expansion efforts are primarily focused on Asian countries and other emerging markets. Thanks to its broad product range, targeted services, and international presence, PerkinElmer can make a significant contribution to meeting the requirements and needs of its customers.

odotettu liikevaihto Revvity on 2,83 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Revvity on 594,24 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Revvity:n hinta-voitto-suhde (P/E) on tällä hetkellä 21,44. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Revvity-osakkeen arvostusta.

Revvity:n hinta-myynti-suhde (P/S) on tällä hetkellä 4,50. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Revvity-osakkeen arvostuskennuslukuna.

Revvity:n Eulpool-laatuscore on 1/10.

Revvity:n ISIN on US7140461093. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Revvity:n WKN on 850943. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Revvity:n ticker on RVTY. Tämä pörssinoteeraus käytetään Revvity-osakkeiden kauppaan pörssissä.

Viimeisten 12 kuukauden aikana Revvity maksoi osinkoa 0,28 USD . Tämä vastaa osingontuottoa noin 0,25 %. Tulevien 12 kuukauden aikana Revvity odotetaan maksavan osinkoa 0,28 USD.

Revvity:n nykyinen osinkotuotto on 0,25 %.

Revvity maksaa osinkoa, joka jaetaan kuukausina , , , .

Revvity maksoi osinkoa joka vuosi viimeisten 36 vuoden aikana.

Tulevien 12 kuukauden aikana odotetaan osinkoja, joiden määrä on 0,28 USD. Tämä vastaa osingontuottoa 0,25 %.

Revvity kuuluu sektoriin 'Terveydenhuolto'.

Saadaksesi viimeisen osingon Revvity:sta päivältä määrässä 0,07 USD, sinulla piti olla osake portfoliossasi ennen irtoamispäivää .

Viimeinen osinko maksettiin .

Vuonna 2025 Revvity jakoi 0,28 USD osinkona.

Revvity:n osingot jaetaan valuutassa USD.